title: Meningitis in diabetic patients.
abstract: Community acquired bacterial (CBM) meningitis in diabetic patients was analyzed for risk factors and outcome in a cohort of 201 cases of meningitis within last 17 years: 15 patients with diabetes mellitus and meningitis were identified and compared for etiology and mortality as well as for neurologic sequellae with all CBM cases.
authors.affiliation: St. Elizabeth University College.
authors.forename: J M
authors.initials: JM
authors.lastname: Muli
authors.forename: S
authors.initials: S
authors.lastname: Seckova
authors.forename: V
authors.initials: V
authors.lastname: Sladeckova
authors.forename: J
authors.initials: J
authors.lastname: Steno
authors.forename: J
authors.initials: J
authors.lastname: Adamcova
authors.forename: L
authors.initials: L
authors.lastname: Rabarova
authors.forename: M
authors.initials: M
authors.lastname: Takacova
authors.forename: J
authors.initials: J
authors.lastname: Polonova
authors.forename: T
authors.initials: T
authors.lastname: Dudasova
authors.forename: K
authors.initials: K
authors.lastname: Pauerova
authors.forename: V
authors.initials: V
authors.lastname: Namulanda
authors.forename: V
authors.initials: V
authors.lastname: Okoth
authors.forename: O
authors.initials: O
authors.lastname: Juma
authors.forename: E
authors.initials: E
authors.lastname: Diana
authors.forename: M J
authors.initials: MJ
authors.lastname: Johnson
authors.forename: J
authors.initials: J
authors.lastname: Deadline
authors.forename: M
authors.initials: M
authors.lastname: Bartkovjak
authors.forename: A
authors.initials: A
authors.lastname: Kolenova
authors.forename: M
authors.initials: M
authors.lastname: Taziarova
authors.forename: J
authors.initials: J
authors.lastname: Benca
authors.forename: Z
authors.initials: Z
authors.lastname: Njambi
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002439:Cefotaxime / Q000627:therapeutic use; D015331:Cohort Studies; D017714:Community-Acquired Infections / Q000382:microbiology / Q000401:mortality / Q000628:therapy; D048909:Diabetes Complications / Q000276:immunology / Q000382:microbiology* / Q000628:therapy; D003920:Diabetes Mellitus / Q000276:immunology*; D006801:Humans; D016920:Meningitis, Bacterial / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D017063:Outcome Assessment, Health Care; D012307:Risk Factors; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002439:Cefotaxime